Objective: To determine how moderate weight loss protocol through diet and exercise may affect changes in body composition, to determine the effects of weight loss on cholesterol metabolism and to examine the relationship between cholesterol metabolism and changes in body composition. Design: Thirty-five otherwise healthy, hypercholesterolemic women completed a 24-week weight loss study. A 20% decrease in energy intake through diet and a 10% increase in energy expenditure by exercise were combined with motivational strategies to encourage weight loss. The diet was self-selected and comprised of 50-60% carbohydrates, 20% protein and o30% fat. Results: Participants lost an average of 11.772.5 kg (Po0.001). Whole body and regional losses in tissue mass occurred after weight loss. After weight loss, cholesterol fractional synthesis rate (FSR) decreased (P ¼ 0.003) 3.8679.33%, whereas rates of cholesterol absorption and turnover did not change (3.31719.4%, P ¼ 0.32 and À0.0176.20%, P ¼ 0.75, respectively). Changes in cholesterol turnover were positively correlated (r ¼ 0.44, P ¼ 0.01) with changes in FSR. Reductions in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were predictive (b ¼ À5.04, r ¼ 0.38; P ¼ 0.03, and b ¼ À147, r ¼ 0.40; P ¼ 0.03, respectively) of increases in cholesterol turnover. Losses in skeletal muscle (SM) and upper-body SM predicted (b ¼ 6.82, r ¼ 0.36; P ¼ 0.04 and b ¼ 14.7, r ¼ 0.41; P ¼ 0.01, respectively) decreases in cholesterol absorption. Conclusions: Decreases in cholesterol synthesis after moderate weight loss are not compensated for by changes in cholesterol absorption or turnover. Changes in regional body composition were associated with variations in cholesterol metabolism. Understanding how weight loss affects cholesterol metabolism will help identify more effective treatment routes for overweight individuals undergoing weight loss resulting in earlier and more intensive therapy for the associated dyslipidemia.
Introduction
The life expectancy of an obese individual has been found to be about 7 years shorter than that of a normal weight counterpart. 1 If current trends in obesity continue, the most recent generation may have a lower lifespan than their parents. 2 Weight loss, however, has recently been shown to increase mortality. 3 One explanation may be that regional changes in body composition, rather than absolute changes in weight, are important in assessing the potential efficacy of weight loss to lower the risk of associated comorbidities and death. Evidence also shows that the presence of large visceral adipose tissue (VAT) depots are associated with increased risk of hypertension, cardiovascular disease (CVD), and type 2 diabetes mellitus (DM). 4, 5 Lapidus et al. 6 reported that women with the highest waist to hip ratio (WHR), an indicator of visceral adiposity, had elevated relative risk of death from CVD. Thus, body composition and fat distribution are important measures in determining potential health benefits of a weight loss program. Decreases in body weight of 10-15% have been shown to produce cardioprotective changes in blood lipid profiles of overweight individuals. 7 Favorable changes in cholesterol levels may be attributed to declines in body fat percent, as shown in previous trials. 8, 9 Additionally, decreases of VAT, resulting from weight loss have been related to reductions in blood lipid levels. 10 Such favourable changes may be explained by the effect of weight loss on cholesterol metabolism. Although few studies have examined effects of weight loss on cholesterol kinetics, those that did have indicated that weight loss may decrease rates of cholesterol synthesis. 11, 12 However, an unresolved question is whether weight loss, and particularly shifts in regional adiposity, affect aspects of cholesterol metabolism including cholesterol absorption, synthesis and turnover. Accordingly, the objectives were (1) to determine how moderate weight loss through diet and exercise may affect changes in whole body and regional body composition, and (2) to determine the effects of total and regional weight loss on cholesterol absorption, synthesis and turnover.
Methods
Subjects Forty-two hyperlipidemic overweight and obese women were recruited by newspaper advertisements and word of mouth from the Montreal area to participate in a 6-month weight loss trial. The sample size was calculated to detect the main effect of weight loss on cholesterol kinetic measurements using an anticipated difference of 20% based on a ¼ 0.05 and b ¼ 0.80. Additional subjects were included in anticipation of dropouts. Inclusion criteria required that the women were 35-60 years of age with body mass indices (BMI) of 28-39 kg/m 2 . As other analyzes were being conducted, subjects were also screened for fasting plasma LDL-C concentrations of 3.4-6.7 mmol/l and TAG concentrations of 41.5 mmol/l. Use of oral antihypertensive agents and thyroid hormones were permitted, provided they were stable and continued throughout the duration of the study. The women were included regardless of menopausal status, provided they were stable on hormone replacement therapy if it was being taken. Fasting blood samples were collected for serum biochemistry and hematology, and subjects were also required to undergo a complete physical examination by a certified medical doctor before acceptance into the study. Subjects were excluded if they underwent oral hyperlipidemic therapy less than 6 months before commencement or if they had a history of chronic illness, including hepatic, renal, gastrointestinal and cardiac dysfunction. Additionally, those who were found to have previous history of eating disorders, chronic laxative use or reported exercise in excess of 4000 kcal/week were excluded. Before commencing, a copy of the study protocol was given to subjects and any queries were answered by the primary investigator or study co-ordinators before signing the consent form. Ethical approval for the experimental protocol was obtained from the Faculty of Medicine Ethics Review Board at McGill University (Montreal, QC, Canada) and the Human Investigation Review Committee of Tufts University (Boston, MA, USA).
Protocol

Experimental design
The trial was 24 weeks in duration and consisted of a 2-week pre-loss stabilization period, a 20-week weight loss period, and a two-week post-loss stabilization period. A period of 2-weeks was used for the stabilization periods to isolate the effects of weight loss by minimizing the effect of diet and exercise on the measured parameters. 13 Subjects served as their own controls in a longitudinal before and after study design.
Participants were required to maintain a stable weight, as well as usual food and exercise habits during the 2-week preand post-loss stabilization periods. During the 2-week stabilization periods, subjects were weighed at days 1, [D 7 ]cholesterol of red blood cell (RBC) cholesterol taken after hours 12, 24, 48 and 72. Deuterium incorporation was used to measure cholesterol synthesis. After a fasting blood sample was taken on day 14 of the stabilization period, subjects imbibed 0.7 g D 2 O/kg estimated body water (99.8 atom percent excess; CDN Isotopes, Montreal). Body water was estimated at 60% of total body weight. Body composition was determined by magnetic resonance imaging (MRI) scans and dietary records were also taken during the two stabilization periods to ensure usual food habits were followed.
Weight loss protocol A 20-week weight loss period was undertaken after the 2-week pre-loss stabilization period. Energy expenditure was estimated using the Harris-Benedict equation multiplied by an activity factor.
14 Weight loss was achieved through a 20% decrease in energy intake by diet restraint combined with a 10% increase in energy expenditure by exercise, resulting in a 30% total energy deficit. In general, prescribed energy intake was between 1400 and 1600 kcal/day. Dietary composition consisted of 50-60% of energy from carbohydrates, 20% of energy from protein, and o30% of energy from fat. The US Exchange System consisting of grains, fruits and vegetables, meat and alternatives, milk, and fat food groups
Cholesterol metabolism, body composition, and weight loss in women S Santosa et al was used to help subjects adhere to dietary guidelines. Monthly individual consultations with nutritionists aided the participants in ensuring dietary adherence throughout the weight loss period. Semi-private meetings with a personal trainer were conducted at the beginning and midway through the weight loss period to help subjects establish exercise routines that would achieve a 10% increase in energy expenditure. Proper techniques were also demonstrated to ensure exercises were carried out safely. Subjects were weighed once a week throughout the weight loss period. An award point system was created to help the subjects keep track of their progress and increase motivation. Additionally, participants were given a graph on which they were able to plot their weekly progress. To increase further motivation and adherence to the weight loss protocol, monthly group sessions were held where guest speakers taught subjects further exercise and nutrition knowledge. Two participants withdrew from the study before the weight loss period owing to inability to undergo MRI scans, and five participants dropped out because of difficulty in following the weight loss regime and adhering to the scheduled study visits.
Analyzes
Plasma lipids
Collected samples were centrifuged at 1500 r.p.m. for 15 min to separate RBC and plasma within 30 min of phlebotomy. Separated aliquots were immediately stored at -201C until analyzed. Plasma total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C) concentrations were analyzed as described previously, using enzymatic or immunoturbidometric reagents and a Hitachi 911 automated analyzer (Roche Diagnostics, Indianapolis, IN, USA), as described previously. 15 The dextran/magnesium sulfate method was used to determine low-density lipoprotein cholesterol (LDL-C) concentrations.
16,17
Cholesterol absorption Determination of cholesterol absorption is described elsewhere. 18, 19 Briefly, lipids were extracted from RBC in duplicate using a modified Folch extraction procedure, and free cholesterol was isolated by thin-layer chromatography. 18 Free cholesterol was then combusted for 4 h at 5401C to 13 C-enriched CO 2 , and D 7 enriched water. 13 C-enriched CO 2 and D 7 -enriched water was separated by vacuum distillation. 19 Isotopic enrichment of the [ ]cholesterol tracers was verified using nuclear magnetic resonance (CDN Isotopes, Pointe Claire, Canada) and were found to be 499 atom% excess. 13 C and D 7 enrichment of free cholesterol was assessed by differential isotope ratio mass spectrometry. 19 Cholesterol absorption coefficient (CAC) where D for 13 C and D 7 is the difference between samples at 48 and 72 h and the baseline abundance (t ¼ 0) in parts per thousand relative to PDB and SMOW standards, respectively. The factors 7/46 and 2/27 reflect the ratio of labeled atoms/mg dose and the constants 0.0112 and 0.000155 are conversion factors of the part per thousand units into atom% excess for the PDB and SMOW scales, respectively.
CAC at 48 and 72 h were then averaged to determine the overall cholesterol absorption.
Cholesterol biosynthesis
Free cholesterol from 72 and 96 h erythrocytes were extracted, as explained earlier, to measure cholesterol synthesis by deuterium incorporation. 18, 21 Additionally, deuterium enrichment of plasma water was determined, as described elsewhere. 19 Fractional synthesis rate (FSR) of cholesterol over 24 h was determined using the following equation that corrects for cholesterol deuterium : protium ratio 21 :
where D refers to deuterium enrichment above baseline level over 24 h in parts per thousand relative to a SMOW standard. The factor 0.478 reflects to ratio of labeled H atoms replaced by deuterium during in vivo biosynthesis. 21 Cholesterol turnover Turnover of plasma-free unesterified cholesterol is defined as the rate of influx from synthesis and dietary absorption compared with the rate of efflux from esterification, excretion or transfer from other body pools. 22 Therefore, turnover rates of erythrocyte-free cholesterol was determined after subtraction of baseline D 7 , [D 7 ]cholesterol enrichment of RBC at 12, 24, 48 and 72 h were fitted to exponential curves to determine the rate of decay.
Body composition measurement by MRI Magnetic resonance images were obtained using a Siemens 1.5. Tesla MRI scanner (Siemens, Mississauga, Canada) using a T-1 weighted spin-echo sequence with a 322 ms repetition time and a 12 ms echo time. 23 Scans of the truncal region, defined by the area between the femoral and humoral heads, were acquired with a scan time of 18 s. Appendicular regional scans, defined as the area above and below the femoral heads and above the humoral heads, were acquired with a scan time of 24 s. The scan was conducted in two parts, divided All MRI data were analyzed using the Slice-O-Matic v. 4.2 rev 8-2e program (Tomovision Inc, Montreal, Canada), as described previously. 23 The volume for each tissue was calculated with the following equation as defined by Ross et al.
23
:
where V represents the total tissue volume, A the tissue area, t the slice thickness, and h the distance between consecutive slices. Volumes were then divided by 1000 to convert into litres and multiplied by the tissue density to convert into kg. The density factors used were 0.94 l/kg for AT and 1.1 l/kg for LT.
24,25
Statistics All data are expressed as means7s.d. Data were tested for normality using the Shapiro-Wilk test. The statistical significance of changes in cholesterol metabolism, body weight, and tissues within each compartment were determined using a Student's paired t-tests. Data that were found to have a non-Gaussian distribution were log-transformed and retested for normality before the paired t-test was applied. The Wilcoxon signed rank test was used for data that did not have a Gaussian distribution after log transformation. Student's t-test was employed to examine differences in percent changes in regional tissue distribution. Data that were found to have a non-Gaussian distribution were log-transformed and retested for normality before the t-test was applied. The Mann-Whitney U-test was applied to compare the percent changes in regional tissue distribution in the event that the data did not have a Gaussian distribution after log transformation. Spearman's rank correlation was used to determine the interactions between cholesterol absorption, FSR and turnover. Linear regression analysis was employed to examine the effects of regional changes in weight loss on cholesterol metabolism as well as the effects of changes in cholesterol metabolism on plasma cholesterol. All values were defined to be statistically significant at Po0.05. Data were analyzed using SPSS for Windows (version 12.0.0; SPSS Inc., Chicago, IL).
Results
Forty-two subjects were recruited to participate with 35 subjects completing the study. (Figure 1 ).
Changes in cholesterol absorption, biosynthesis and turnover in response to weight loss TC and LDL-C levels declined by 0.62.70.65 mmol/l (Po0.001) and 0.3270.51 mmol/l (P ¼ 0.001), respectively, and HDL-C increased (P ¼ 0.03) by 0.0870.21 mmol/l after weight loss.
After weight loss, FSR was reduced (P ¼ 0.003) by 3.8679.33 %/day (15.2791.0% relative to initial). No significant changes in cholesterol absorption (3.31719.4%, P ¼ 0.32; 12.1737.2% relative to initial) or rates of cholesterol turnover (-0.0176.20%, P ¼ 0.75; 3.17730.3% relative to initial) were found. Despite the lack of change found in cholesterol turnover, a relationship was found (P ¼ 0.01) between FSR and turnover, where decreases in FSR correlated (r ¼ 0.44) with declines in turnover rates of free cholesterol (see Figure 2) . No relationship was detected between changes in cholesterol absorption and changes in FSR or between changes in cholesterol absorption and turnover rates.
Overall changes in whole body composition after weight loss Overall, participants lost an average of 11.772.5 kg (14.573.1% of original body weight) (Po0.001) after Cholesterol metabolism, body composition, and weight loss in women S Santosa et al following the 20-week weight loss protocol. Figure 1 shows the weight and percent whole body composition of SM, SAT, LT and AT before and after the weight loss period. (Figure 3 ).
Regional changes in body composition after weight loss
Reductions in percentage SAT in the upper body (-33.3%.7 12.1%) were greater (P ¼ 0.038) than those found in the lower body (-27.9%78.81%). Percent changes in the proportions of SM, LT and AT of upper body and lower body did not significantly differ (Figure 4 ). In the abdominal region, the decline in AT after weight loss was 2.6071.14 kg (Po0.001), whereas there was no change in LT. SM, SAT and VAT decreased (Po0.001) by 0.1770.18, 1.9470.86 and 0.6170.47 kg, respectively. At the end of the weight loss treatment, the percent whole body AT composition of SAT from the abdominal region dropped by 1.1871.50% (Po0.001), and the percent composition of AT from the abdomen was reduced 0.9971.63% (Po0.001). No changes in the percent composition of VAT were found. There were no differences in the VAT:SAT ratio after weight loss.
Relationship between changes in whole and regional body composition and cholesterol metabolism Larger reductions in VAT predicted rises in cholesterol turnover rate (b ¼ -5.04,. r ¼ 0.38; P ¼ 0.03) (see Figure 5a ).
The changes in cholesterol turnover rate was also negatively predicted by greater declines in the VAT:SAT ratio (b ¼ -147, r ¼ 0.40; P ¼ 0.03) (see Figure 5b) . With regard to cholesterol absorption, larger losses in SM predicted greater decreases (b ¼ 6.82, r ¼ 0.36; P ¼ 0.04) (see Figure 6a) . Changes in cholesterol absorption were also positively predicted by changes in upper body SM (b ¼ 14.7, r ¼ 0.41; P ¼ 0.01) (see Figure 6b) . No other changes in whole or regional body composition were predictive of changes in cholesterol metabolism.
Discussion
The novel findings of this study are that changes in cholesterol turnover after weight loss were negatively predicted by changes in VAT and VAT:SAT, and that changes in cholesterol absorption were positively predicted by changes in total and upper body SM. Moreover, cholesterol FSR decreases in absence of any changes in cholesterol absorption or turnover rate after moderate weight loss in women, and that decreases in FSR are related to decreases in cholesterol turnover. Weight loss resulted in favorable changes in plasma cholesterol concentrations suggesting an amelioration of CVD risk. Cholesterol metabolism, body composition, and weight loss in women S Santosa et al
The importance of regional body composition on morbidity and mortality has been well-established. To our knowledge, this is the first study in women to examine effects of self-directed diet and exercise on regional body composition using MRI. Mean weight loss of about 12 kg in this trial resulted in whole body reductions in SM, SAT, LT and AT mass. Other trials that saw comparable weight loss achieved similar losses in SAT and AT to those found in the present study. 8, 26 Additionally, this study observed significant decreases in SM that were not found in similar trials. 8, 26, 27 Of particular note is that these trials also included a diet only group, which had significant and comparable losses in SM as those found in the present study. 8, 26, 27 The exercise intervention, however, in these weight loss trials was conducted under supervision, thereby allowing for control of the intensity and type of exercise conducted. The self-selected exercise in the present study may have been conducted at a lower intensity, possibly explaining the disparity in body composition changes between this and other studies. 8, 26, 27 Despite losses in SM, increases in the LT:AT ratio in this study suggest that the proportion of LT that is preserved is greater than the proportion of AT that is lost. This observation is especially important as losses in LT may be related to higher mortality, whereas losses in AT may be related to lower mortality. 3 Some of the health benefits derived from weight loss are related to CVD risk factors. The moderate weight loss in this study was associated with decreases in TC, LDL-C, and TAG, as well as increases in HDL-C levels, apparently caused by shifts in cholesterol metabolism. Experiments in men indicate decreases in cholesterol synthesis after weight loss. 11, 12 However, the decline in synthesis found in the present study after an approximate 12 kg weight loss in women were less than those found in these other studies in men. One of the reasons for this may be because cholesterol metabolism measurements in this experiment were taken after stabilization periods that minimize the effect of the diet and exercise weight loss method. Di Buono et al. 11 found decreases in FSR of about 5-6% after a weight loss of 3-8 kg in six men following the AHA Step I diet with a caloric deficit of 1000 kJ/day. Another study in males fed a low-fat diet showed that losses of 3 kg of body weight were accompanied Cholesterol metabolism, body composition, and weight loss in women S Santosa et al by larger reductions in FSR compared to those found presently. 12 Contrary to these findings, a trial by Griffin et al. 28 that included men and women type 2 diabetics found no differences in fasting cholesterol synthesis measured by [
14 C]-acetate after a diet-induced weight loss of about 7-8 kg. Despite the fact that the present study included a larger number of subjects and achieved greater weight loss than previous trials, the decrease in cholesterol synthesis after moderate weight loss was attenuated. This was the only trial, however, to limit inclusion of subjects to women. Thus, though cholesterol synthesis decreases, this may indicate that its response to weight loss may be less pronounced in women than in men. This is the first use of MRI to determine how changes in body composition may affect cholesterol metabolism. Although a relationship has been established between abdominal AT compartments and WHR, WHR cannot accurately predict changes in these compartments. 29 Accurate assessment of VAT requires use of MRI or computed tomography. 30 Thus, in addition to assessing whole body composition, the use of MRI in this study allowed for a precise examination of abdominal tissue distribution. As a result, significant decreases in total abdominal AT, abdominal SAT and VAT were found. The loss of VAT in this study has positive implications on health as VAT has been positively associated with increased risk of metabolic aberrations and death. 4, 6 Losses of 0.6 kg VAT observed in the present study were comparable with those found in other diet and exercise weight loss studies. 8, 26 Additionally, larger changes in VAT predicted smaller shifts in cholesterol turnover. The observation that the change of the VAT:SAT ratio is correlated with cholesterol turnover may be attributed mainly to changes in VAT, as changes in SAT did not independently predict changes in cholesterol turnover. A possible explanation for these observations is that cholesterol mobilized from visceral adipocytes is drained by the portal vein, which travel to the liver. 31 As the liver is a primary metabolic site, a greater influx of cholesterol from larger losses in VAT depots may decrease cholesterol turnover by increasing influx relative to a constant rate of efflux. Differences in cholesterol turnover were also positively related to cholesterol synthesis. Whether changes in one predict changes in the other cannot be determined as variations in cholesterol turnover are predicted by changes in VAT, which may in turn affect rates of biosynthesis. It is possible that differences in synthesis following weight loss may result in proportional changes in turnover because synthesis itself may be reduced as a direct cause of a decrease in liver size. Previously, cholesterol synthesis per gram of hepatic tissue has been found to be equivalent in obese and non-obese individuals. 32, 33 Additionally, liver biopsies from normal and obese individuals indicated that obese individuals had higher expression of the HMG CoA reductase and other enzymes involved in cholesterol synthesis. 32 Neither a change in cholesterol absorption nor a relationship between change in cholesterol synthesis and absorption was detected after weight loss. However, previous experiments in metabolism of cholesterol indicate the potential for a reciprocal relationship in absorption and synthesis where change in one parameter oppositely affects the other. 19, [34] [35] [36] [37] [38] A paucity of trials exists which measure the effects of weight loss on both absorption and synthesis. The only research found was in subjects with type 2 diabetes mellitus (DM) using plant sterol and cholesterol precursors as indicators of absorption and synthesis. 39, 40 Although, both studies indicated a decrease in synthesis and an increase in absorption after weight loss, the methods used only a crude estimation of cholesterol kinetics, as plant sterols and cholesterol precursors might be affected by diet and are not quantitative measures of metabolism. [39] [40] [41] The use of isotope ratio methodology in this trial offers a more precise quantifiable measure of cholesterol metabolism and, thus, may explain the differences in findings between this and other studies. Despite the absence of change in cholesterol absorption, increases in total body SM predicted increases in cholesterol absorption. The ability of total body SM to predict absorption is likely attributed to increases in upper body SM, as upper and not lower body SM was found to be a predictor of cholesterol absorption. Although the reason that changes in SM predicted changes in cholesterol absorption is unclear, we postulate that it might be due to an elevation in demand of cholesterol, which is needed to build myocytes.
In summary, moderate weight loss achieved in female participants of the present study resulted in decreases in cholesterol biosynthesis in the absence of any changes in cholesterol absorption and turnover. The use of MRIs in this study showed that significant weight loss as a result of a self-directed diet and exercise program resulted in favorable changes in regional and whole body SM, SAT and VAT, as well as AT. For the first time, we were able to examine how regional changes in regional body composition affected cholesterol metabolism. More specifically, decreases in VAT and VAT:SAT predicted increases in cholesterol turnover, and increases in whole and upper body SM predicted increases in cholesterol absorption. Understanding changes in cholesterol metabolism resulting from weight loss may help identify better treatment routes for individuals at increased risk of cardiovascular disease and allow for earlier and more intensive therapy for the associated dyslipidemia.
